TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Kappa Bioscience AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 308,808 | 237,967 | 282,766 |
Financial expenses | 23,517 | 45,062 | 15,870 |
Earnings before taxes | 71,151 | 70,717 | 82,783 |
Total assets | 497,911 | 367,374 | 276,388 |
Current assets | 227,038 | 263,611 | 185,803 |
Current liabilities | 153,980 | 93,525 | 85,937 |
Equity capital | 268,611 | 236,048 | 182,382 |
- share capital | 1,608 | 1,560 | 1,452 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 53.9% | 64.3% | 66.0% |
Turnover per employee | |||
Profit as a percentage of turnover | 23.0% | 29.7% | 29.3% |
Return on assets (ROA) | 19.0% | 31.5% | 35.7% |
Current ratio | 147.4% | 281.9% | 216.2% |
Return on equity (ROE) | 26.5% | 30.0% | 45.4% |
Change turnover | 63,467 | -65,785 | 89,002 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.